These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34924308)

  • 41. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study.
    Brlić PK; Pavletić M; Lerga M; Krstanović F; Matešić MP; Miklić K; Malić S; Mikša L; Pajcur M; Peruč D; Schubert M; Bertoglio F; Arapović J; Protić A; Šustić A; Milošević M; Šain LČ; Jonjić S; Lisnić VJ; Brizić I
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
    Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
    Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
    Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
    J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and Evaluation of Quantitative Immunoglobulin G Enzyme-Linked Immunosorbent Assay for the Diagnosis of Coronavirus Disease 2019 Using Truncated Recombinant Nucleocapsid Protein as Assay Antigen.
    Mutantu PN; Ngwe Tun MM; Nabeshima T; Yu F; Mukadi PK; Tanaka T; Tashiro M; Fujita A; Kanie N; Oshiro R; Takazono T; Imamura Y; Hirayama T; Moi ML; Inoue S; Izumikawa K; Yasuda J; Morita K
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation and performance comparison of three SARS-CoV-2 antibody assays.
    Paiva KJ; Grisson RD; Chan PA; Huard RC; Caliendo AM; Lonks JR; King E; Tang EW; Pytel-Parenteau DL; Nam GH; Yakirevich E; Lu S
    J Med Virol; 2021 Feb; 93(2):916-923. PubMed ID: 32710669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection.
    Choudhary HR; Parai D; Dash GC; Peter A; Sahoo SK; Pattnaik M; Rout UK; Nanda RR; Pati S; Bhattacharya D
    Infection; 2021 Oct; 49(5):1045-1048. PubMed ID: 34213733
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan.
    Lin YC; Lee YL; Cheng CY; Tseng WP; Wu JL; Lin CH; Chung MY; Kang CM; Lee YF; Chen CP; Huang CH; Liu CE; Cheng SH; Chen SC; Chen SY; Hsueh PR
    J Microbiol Immunol Infect; 2021 Oct; 54(5):816-829. PubMed ID: 33676864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.
    Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL
    Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients.
    Kurano M; Ohmiya H; Kishi Y; Okada J; Nakano Y; Yokoyama R; Qian C; Xia F; He F; Zheng L; Yu Y; Jubishi D; Okamoto K; Moriya K; Kodama T; Yatomi Y
    Front Immunol; 2022; 13():811952. PubMed ID: 35126396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Performances of Three Commercially Available Assays for the Detection of SARS-CoV-2 Antibodies at Different Time Points Following SARS-CoV-2 Infection.
    Syre H; Obreque MEB; Dalen I; Riis ÅG; Berg Å; Löhr IH; Sundal J; Kleppe LK; Vadla MS; Lenning OB; Olofsson JS; Mohn KG; Tøndel C; Blomberg B; Trieu MC; Langeland N; Cox RJ
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies.
    Garritsen A; Scholzen A; van den Nieuwenhof DWA; Smits APF; Datema ES; van Galen LS; Kouwijzer MLCE
    Infect Dis (Lond); 2021 Jul; 53(7):498-512. PubMed ID: 33684020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021.
    Abe KT; Rathod B; Colwill K; Gingras AC; Tuite A; Robbins NF; Orjuela G; Jenkins C; Conrod V; Yi QL; O'Brien SF; Drews SJ
    Microbiol Spectr; 2022 Jun; 10(3):e0113422. PubMed ID: 35652636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Antibody Class-Specific SARS-CoV-2 Serologies for the Diagnosis of Acute COVID-19.
    Verkerke H; Horwath M; Saeedi B; Boyer D; Allen JW; Owens J; Arthur CM; Nakahara H; Rha J; Patel K; Wu SC; Paul A; Yasin N; Wang J; Shin S; Brown D; Normile K; Cole L; Meyers M; Lin H; Woods E; Isaac J; Broder K; Wade J; Kauffman RC; Patel R; Josephson CD; Reynolds S; Sherman M; Wrammert J; Alter D; Guarner J; Roback JD; Neish A; Stowell SR
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33468605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19.
    Fhied CL; Tarhoni I; Gerard D; Lewin GM; Moudgalya H; Schneider JR; Borgia JA
    J Vis Exp; 2022 Feb; (180):. PubMed ID: 35253789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The kinetics and predictors of anti-SARS-CoV-2 antibodies up to 8 months after symptomatic COVID-19: A Czech cross-sectional study.
    Štěpánek L; Janošíková M; Štěpánek L; Nakládalová M; Boriková A
    J Med Virol; 2022 Aug; 94(8):3731-3738. PubMed ID: 35419860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vertical transmission and humoral immune response following maternal infection with SARS-CoV-2: a prospective multicenter cohort study.
    Massalha M; Yefet E; Rozenberg O; Soltsman S; Hasanein J; Smolkin T; Alter A; Perlitz Y; Nachum Z
    Clin Microbiol Infect; 2022 Sep; 28(9):1258-1262. PubMed ID: 35427778
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibody Response to the SARS-CoV-2 Spike and Nucleocapsid Proteins in Patients with Different COVID-19 Clinical Profiles.
    Soares SR; da Silva Torres MK; Lima SS; de Sarges KML; Santos EFD; de Brito MTFM; da Silva ALS; de Meira Leite M; da Costa FP; Cantanhede MHD; da Silva R; de Oliveira Lameira Veríssimo A; Vallinoto IMVC; Feitosa RNM; Quaresma JAS; Chaves TDSS; Viana GMR; Falcão LFM; Santos EJMD; Vallinoto ACR; da Silva ANMR
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of dried blood spot sampling for detecting SARS-CoV-2 antibodies and total immunoglobulins in a large cohort of asymptomatic young adults.
    Ferentinos P; Snape D; Koivula F; Faustini S; Nicholson-Little A; Stacey M; Gifford R; Parsons I; Lamb L; Greeves J; O'Hara J; Cunningham AF; Woods D; Richter A; O'Shea MK
    J Immunol Methods; 2023 Jul; 518():113492. PubMed ID: 37201783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selection, Characterization, Calibration, and Distribution of the U.S. Serology Standard for Anti-SARS-CoV-2 Antibody Detection.
    Kemp TJ; Quesinberry JT; Cherry J; Lowy DR; Pinto LA
    J Clin Microbiol; 2022 Nov; 60(11):e0099522. PubMed ID: 36222529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.